08/07/2025
7:33 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
7:36 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
7:42 PM | Alenson Carman (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:42 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:42 PM | Cahill Thomas (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | Chung Wendy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | Foster-Cheek Kaye I (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | Kelly Michael Aaron (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
7:43 PM | Prime Medicine (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PRME and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. |
08/05/2025
7:44 PM | LEE ANN L. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2025
6:18 PM | ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Burow Kristina (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2025
6:19 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2025
6:19 PM | NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2025
4:14 PM | Prime Medicine (Filer)
| Form 424B5 | |
07/31/2025
4:16 PM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:38 PM | Prime Medicine (Filer)
| Form DEF 14A | |
07/02/2025
3:44 PM | Prime Medicine (Filer)
| Form PRE 14A | |
06/23/2025
3:33 PM | Liu David R. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:14 PM | Liu David R. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2025
3:49 PM | Liu David R. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:11 PM | Cahill Thomas (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:13 PM | Chung Wendy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:13 PM | Foster-Cheek Kaye I (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:13 PM | Kelly Michael Aaron (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:13 PM | NELSEN ROBERT (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:13 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:14 PM | Prime Medicine (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
3:18 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
3:21 PM | LEE ANN L. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2025
3:22 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
6:44 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
6:45 PM | Marrazzo Jeffrey D (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
8:09 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
8:12 AM | Prime Medicine (Filer)
| Form DEFA14A | |
05/12/2025
3:48 PM | LEE ANN L. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
3:50 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
3:50 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:05 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:08 AM | Prime Medicine (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
04/22/2025
5:19 AM | Prime Medicine (Filer)
| Form ARS | |
04/22/2025
5:09 AM | Prime Medicine (Filer)
| Form DEFA14A | |
04/22/2025
5:07 AM | Prime Medicine (Filer)
| Form DEF 14A | |
03/18/2025
6:15 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
7:11 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:12 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:14 PM | LEE ANN L. (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:15 PM | Duffield Jeremy (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:16 PM | Goldwasser Meredith (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:18 PM | Alenson Carman (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
7:13 AM | Prime Medicine (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2025
7:21 AM | Prime Medicine (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:02 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:01 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2024
11:15 PM | Prime Medicine (Filer)
| Form EFFECT | |
12/13/2024
7:18 AM | Prime Medicine (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/09/2024
5:22 PM | Prime Medicine (Issuer)
Reine Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:22 PM | Brudnick Richard (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:23 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:32 PM | ARCH Venture Fund XII, L.P. (Filed by)
Prime Medicine (Subject)
| Form SC 13D/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Prime Medicine (Subject)
| Form SC 13G/A | |
10/24/2024
7:04 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
3:29 PM | Gottesdiener Keith Michael (Reporting)
Prime Medicine (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:20 PM | BRISTOL MYERS SQUIBB CO (Filed by)
Prime Medicine (Subject)
| Form SC 13G | |
09/30/2024
6:38 AM | Prime Medicine (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PRME Stock Alerts